Levovar

Carbidopa/Levodopa, the active ingredient in Levovar, is an antiparkinson agent presented as an oral tablet for oral use. It is prescribed to manage the motor symptoms of Parkinson's disease and related Parkinsonian syndromes in adult patients.

GNH USA supplies Levovar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, batch traceability and dedicated regulatory support for its partners across global markets.

Levovar (carbidopa/levodopa) is used within the antiparkinson therapeutic pathway to improve dopaminergic function in several movement disorders.

- Parkinson's disease: reduces bradykinesia, rigidity and tremor, improving daily motor function. - Parkinsonian syndrome: alleviates motor deficits caused by secondary or atypical Parkinsonism. - Dopa‑responsive dystonia: restores normal movement by compensating for deficient dopamine synthesis.

Levovar may cause a range of adverse reactions, from mild to serious. Awareness of these effects helps clinicians monitor patients effectively.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually self‑limiting. - Insomnia: difficulty initiating or maintaining sleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements that may be disabling. - Psychosis: visual hallucinations or delusional thinking. - Severe hypotension: marked drop in blood pressure leading to fainting.

When prescribing Levovar, clinicians should observe several safety measures to minimize risk.

- Dose titration: increase dose gradually under medical supervision. - Monitor for dyskinesia: watch for involuntary movements during therapy. - Assess cardiovascular status: be alert to orthostatic hypotension. - Avoid abrupt discontinuation: sudden stop may worsen motor symptoms. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Levovar can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Pyridoxine (vitamin B6) at high doses: reduces levodopa efficacy. - Antipsychotics (dopamine antagonists): may negate therapeutic effect.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure lowering effect. - SSRIs and other serotonergic agents: potential for serotonin syndrome. - Other dopaminergic agents: may increase risk of dyskinesia.